FFCP PHASE1:Hg19::chrX:11778510..11778522,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport=supported | |||
|DPIdataset=robust | |||
|EntrezGene=10943 | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=gencodeV16_protein_coding | |||
|HGNC=7370 | |||
|TSSclassifier=not | |||
|UniProt= | |||
|association_with_transcript=-71bp_to_ENST00000487782_5end | |||
|coexpression_cluster_id=C631 | |||
|description=CAGE_peak_19_at_MSL3_5end | |||
|id=chrX:11778510..11778522,+ | |||
|ontology_enrichment_celltype=CL:0002087!7.73e-19!119;CL:0000838!2.81e-18!52;CL:0000542!8.02e-18!53;CL:0000051!8.02e-18!53;CL:0002031!1.79e-16!124;CL:0000738!1.11e-15!140;CL:0000037!6.58e-12!172;CL:0000566!6.58e-12!172;CL:0002032!6.82e-12!165;CL:0000837!6.82e-12!165;CL:0000988!9.51e-11!182;CL:0000623!7.31e-09!3;CL:0000825!7.31e-09!3;CL:0000791!1.84e-08!18;CL:0000789!1.84e-08!18;CL:0002420!1.84e-08!18;CL:0002419!1.84e-08!18;CL:0000790!1.84e-08!18;CL:0000945!3.32e-08!24;CL:0000826!3.32e-08!24;CL:0000084!3.17e-07!25;CL:0000827!3.17e-07!25;CL:0002057!8.42e-07!42 | |||
|ontology_enrichment_celltype_v019=CL:0000946;2.45e-26;1!CL:0000786;2.45e-26;1!CL:0000945;4.70e-26;24!CL:0000746;1.30e-09;3!CL:0000542;6.49e-08;53!CL:0000737;1.59e-07;4!CL:0002087;2.32e-07;104 | |||
|ontology_enrichment_celltype_v019_2=CL:0000946,2.78e-26,1;CL:0000786,2.78e-26,1;CL:0000980,2.78e-26,1;CL:0000945,4.70e-26,24;CL:0000826,4.70e-26,24;CL:0000838,2.99e-17,52;CL:0000542,6.27e-17,53;CL:0000051,6.27e-17,53;CL:0000785,7.30e-14,2;CL:0000955,7.30e-14,2;CL:0000818,7.30e-14,2;CL:0000954,7.30e-14,2;CL:0000816,7.30e-14,2;CL:0002087,1.76e-10,115;CL:0002031,4.78e-10,120;CL:0000817,1.10e-09,3;CL:0000746,1.30e-09,3;CL:0000513,1.30e-09,3;CL:0000738,7.24e-09,136;CL:0000737,1.59e-07,4;CL:0002032,1.75e-07,161;CL:0000837,1.75e-07,161;CL:0000037,3.63e-07,168;CL:0000988,8.50e-07,177 | |||
|ontology_enrichment_development_v019=CL:0000954;6.85e-14;2!CL:0000513;1.30e-09;3!CL:0000051;6.49e-08;53 | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019=DOID:630;8.64e-26;1!DOID:0050177;8.64e-26;1!DOID:0050427;8.64e-26;1 | |||
|ontology_enrichment_disease_v019_2=DOID:630,9.79e-26,1;DOID:0050177,9.79e-26,1;DOID:0050427,9.79e-26,1 | |||
|ontology_enrichment_uberon= | |||
|ontology_enrichment_uberon_v019= | |||
|ontology_enrichment_uberon_v019_2= | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0.123766352960047,0,0,0,0,0,0,0,0,0,0,0,1.29902789771517,0.57470412614962,0.629686250509434,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.145398238779565,0,0,0,0,0.309706370895104,0,0.256160706529101,0,0.689491361473237,0,0,0.188242339542605,0.272906150057846,0.224723484445085,0.306083892370903,0,0,0.659702600373432,0,0,0.870627715885752,0,0,0,0,0,0,0,1.89877432464531,0,0,0,0.22465726229299,0,0,0,0,0,0,0,0,0,0,0.574752439954483,0,0,0,0,0,0,0.560508562981536,0,0,1.17903228824749,0.205601498999509,0,0.651844533267181,0,0,0.111410456885174,0,0,0,0,0,0,0,0,0.741432815810302,0,0,0,0,0,0,0,0.651083453856419,0,0.150575119077773,0.255973222308837,0,0,0,0.201606743224732,0,0.289648807765598,2.43806866313962,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.132957960518865,0,0,0,0,0,0,0,0.838998872419812,0,0.208994966536811,0,0,0,0,0,0,0,0,0.0892997282840798,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.140450806702248,0,0,0.103325781175765,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.116193942869518,0.10366105501537,0,0,0,0,0,0,0,0,0.168584690078102,0,0,0,0,0.134831308160164,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.190254152234598,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.129271715757778,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.099972991182057,0,0,0,0,0,0,0,0,0,0,0.197030760201927,0.646882724578552,0.256686072559497,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.206768026122887,0,0,0,0,0,0.248107807818777,0,0,0.128139149255701,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.215915916102139,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.127612712494584,0,0,0,0,0,0,0,0,0.143124886741991,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5.53881624574813,0,0.0898683511473268,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.189753732724185,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0633107959558787,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.262887354279314,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.25426853765475,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.197611631897944,3.65377795142688,0,0,0,0,0,0,0,0.244052529803926,0,0,0,0,0,0,0,0,0,0,0,0,0.233713309847224,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.400027764663154,0,0,0,0,0,0.260994291965212,0,0,0,0.179088841081487,0,0.219284049578707,0,0,0,0,0,0,0,0,0.132864840313363,0,0,0,0,0,0,0.172214979660816,0,0,0,0,0.127894371303652,0,0,0,0,0,0.123935764259002,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5.18552944001007,0,0,0,0,0,0,0.157115589916002,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.299823467774787,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.250707539292375,0,0,0.829169439458779,0,0,0,0.452122368852043,0.31037357147929,0,0,0,0,0,0.336760265072938,0,0,0,0,0,0,0,0,0,0,0,1.28227396921293 | |||
|short_description=p19@MSL3 | |||
}} |
Revision as of 04:48, 23 January 2014
Short description: | p19@MSL3 |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | No |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_19_at_MSL3_5end |
Coexpression cluster: | C631_b_plasma_xeroderma_lymphoma_splenic_Burkitt_B |
Association with transcript: | -71bp_to_ENST00000487782_5end |
EntrezGene: | MSL3 |
HGNC: | 7370 |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
antibody secreting cell | 2.78e-26 | 1 |
plasma cell | 2.78e-26 | 1 |
plasmablast | 2.78e-26 | 1 |
lymphocyte of B lineage | 4.70e-26 | 24 |
pro-B cell | 4.70e-26 | 24 |
lymphoid lineage restricted progenitor cell | 2.99e-17 | 52 |
lymphocyte | 6.27e-17 | 53 |
common lymphoid progenitor | 6.27e-17 | 53 |
mature B cell | 7.30e-14 | 2 |
pre-B-II cell | 7.30e-14 | 2 |
transitional stage B cell | 7.30e-14 | 2 |
small pre-B-II cell | 7.30e-14 | 2 |
immature B cell | 7.30e-14 | 2 |
nongranular leukocyte | 1.76e-10 | 115 |
hematopoietic lineage restricted progenitor cell | 4.78e-10 | 120 |
precursor B cell | 1.10e-09 | 3 |
cardiac muscle cell | 1.30e-09 | 3 |
cardiac muscle myoblast | 1.30e-09 | 3 |
leukocyte | 7.24e-09 | 136 |
striated muscle cell | 1.59e-07 | 4 |
hematopoietic oligopotent progenitor cell | 1.75e-07 | 161 |
hematopoietic multipotent progenitor cell | 1.75e-07 | 161 |
hematopoietic stem cell | 3.63e-07 | 168 |
hematopoietic cell | 8.50e-07 | 177 |
Ontology term | p-value | n |
---|---|---|
genetic disease | 9.79e-26 | 1 |
monogenic disease | 9.79e-26 | 1 |
xeroderma pigmentosum | 9.79e-26 | 1 |